CEN Biotech Inc (CENBF)
0.0033
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
CEN Biotech Accounts Receivable (Quarterly): 0.1022M for March 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.1022M |
| December 31, 2022 | 0.1092M |
| September 30, 2022 | 0.0113M |
| June 30, 2022 | 0.1039M |
| March 31, 2022 | 0.1637M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.1931M |
| September 30, 2021 | 0.1644M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
0.1931M
Maximum
Dec 2021
0.106M
Average
0.1066M
Median
Accounts Receivable (Quarterly) Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | 0.3729M |
| Venus Concept Inc | 29.15M |
| Juva Life Inc | 0.4252M |
| Lucy Scientific Discovery Inc | 0.0006M |